Diagnosis: The Life-or-Death First Step Millions with Bleeding Disorders Cannot Take

MONTREAL, QC – April 17, 2026 – As landmarks across the globe light up in red tonight, the World Federation of Hemophilia (WFH) is issuing a stark reminder on World Hemophilia Day: for hundreds of thousands of people, the most fundamental step in healthcare—a diagnosis—remains an impossible dream. This year's theme, "Diagnosis: First step to care," casts a harsh light on a staggering global health inequity, with the WFH estimating that over three-quarters of the global population with hemophilia are undiagnosed and untreated.

The gap is even more profound for other inherited bleeding disorders like von Willebrand disease (VWD), meaning millions live in the shadow of a condition they cannot name, suffering from symptoms that are often dismissed or misunderstood. For these individuals, a life of chronic pain, debilitating joint damage, and the constant threat of a life-endangering bleed is the norm. Without a diagnosis, there is no treatment, and without treatment, there is no hope for a better quality of life.

A Global Chasm in Care

The disparity in diagnosis is a tale of two worlds. In high-income countries, patient identification for hemophilia approaches 100%. But in lower-income nations, that figure plummets to as low as 12%. Research shows that the median age of diagnosis for a child in a low-income country can be delayed by decades compared to one in a wealthier nation. For severe hemophilia, a child in parts of Africa may not be diagnosed until they are over four years old, while a child in the Americas is typically diagnosed around eight months.

"Accurate diagnosis is the gateway to care for people living with bleeding disorders," stated Cesar Garrido, WFH President, in a press release. "Yet in many parts of the world, barriers continue to delay or prevent proper diagnosis—leading to unacceptably low diagnosis rates. The challenge is even greater for people with von Willebrand disease, rare bleeding disorders, and for women and girls with bleeding disorders."

This challenge is amplified for women. The long-held misconception that hemophilia is an exclusively male disease has left countless women and girls undiagnosed. Recent WFH data indicates nearly one-third of people with hemophilia may be female, yet they face systemic healthcare barriers and social stigma that prevent them from seeking or receiving a proper diagnosis. Similarly, VWD, which may affect up to 1% of the population, is chronically underdiagnosed, with an average delay of 16 years from the onset of symptoms. Symptoms like heavy menstrual bleeding are often normalized or dismissed, leaving women to suffer in silence.

The Crippling Cost of the Unknown

For those living without a name for their condition, the consequences are devastating. A swollen knee is mistaken for a simple sports injury, a prolonged nosebleed is blamed on the weather. In reality, these are internal bleeds that, left untreated, cause irreversible joint destruction, chronic pain, and permanent mobility issues. The lack of a diagnosis means no access to life-saving clotting factor therapies or other modern treatments.

The burden extends far beyond the physical. Families are caught in a cycle of confusion and crisis, watching a loved one suffer without understanding why. The economic impact is immense, with parents sometimes forced to leave careers to care for a child with unexplained and severe health problems. The psychological toll of living with an invisible, untreated illness creates a pervasive sense of anxiety and isolation for both patients and their caregivers.

This reality stands in stark contrast to the lives of those who have received a diagnosis. With proper treatment and management, people with bleeding disorders can live full, active lives, pursue careers, have families, and contribute fully to their communities. The diagnosis itself is the key that unlocks this potential.

Forging a Path to Diagnosis

Closing this vast diagnostic gap requires a multi-pronged, global effort. The WFH's call to action targets governments, healthcare providers, and advocates, urging them to confront these inequities head-on. The focus is on tangible, sustainable solutions: strengthening the skills of healthcare professionals and enhancing the effectiveness of laboratories.

In many resource-constrained regions, the primary healthcare system is overwhelmed by infectious diseases, leaving rare disorders like hemophilia on the sidelines. There is often a severe lack of trained hematologists and laboratory technicians who can perform and interpret the specific coagulation tests required for an accurate diagnosis. Furthermore, the necessary equipment and reagents are often unavailable or prohibitively expensive.

Initiatives are underway to change this. Community-based screening programs, such as mobile testing units, are being explored to bring basic diagnostic services directly to underserved populations. The WFH and its national member organizations are working to provide training and tools to local healthcare providers, empowering them to identify, support, and treat people in their own communities. The support of corporate partners and pharmaceutical firms is crucial in funding these programs, supporting patient registries, and improving access to therapies once a diagnosis is made.

From Shadow to Light: The Power of a Name

Despite the daunting statistics, there are signs of progress. Advocacy efforts are beginning to yield results, with a reported 9% increase in the identification of women and girls with bleeding disorders in the WFH's most recent global survey. This highlights the impact of targeted campaigns to dismantle stigma and educate both the public and medical professionals.

The establishment of the WFH World Bleeding Disorders Registry (WBDR) is another critical step forward. By collecting standardized patient data from around the globe, the registry provides invaluable insights into the prevalence of these disorders, identifies gaps in care, and equips advocates with the hard evidence needed to lobby for policy changes and increased funding.

For every individual who receives a diagnosis, the world changes. It is a moment of validation, a release from years of uncertainty, and the first step on a path toward managing their condition and reclaiming their life. As communities around the world participate in the "Light it Up Red!" campaign and share their stories, the message is clear: a diagnosis is more than a medical term; it is a fundamental human right and the essential first step toward the WFH's vision of Treatment for All.